Emcure Independent Director Jayakumar Completes 2nd Term

Key Event Details

Mr. P.S. Jayakumar (DIN: 01173236) has completed his 2nd consecutive term as an Independent Director of Emcure Pharmaceuticals Limited. Consequently, he ceases to be a Director of the Company with effect from close of business hours on July 21, 2026.

Committee Composition Changes

Consequent to his cessation as Independent Director, Mr. Jayakumar also ceases to hold the following Board Committee positions effective July 21, 2026:

• Chairman of the Audit Committee
• Member of the Nomination and Remuneration Committee
• Member of the Risk Management Committee

Board Acknowledgement

The Board of Directors placed on record its appreciation for the contributions made by Mr. Jayakumar during his tenure as Independent Director of the Company.

Financial Impact

No financial impact quantified in the disclosure. This is a corporate governance update with no immediate capital structure or cash flow implications.

#Tags: #EmcurePharmaceuticals #SEBIRegulation30 #CorporateGovernance #BoardComposition #ManagementChange